These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3554674)

  • 1. Pseudoporphyria cutanea tarda associated with cyclosporine therapy.
    Solá R; Puig LL; Ballarin JA; Doñate T; del Río G
    Transplantation; 1987 May; 43(5):772. PubMed ID: 3554674
    [No Abstract]   [Full Text] [Related]  

  • 2. [Naproxen-induced bullous photodermatitis (pseudoporphyria)].
    Lützow-Holm C
    Tidsskr Nor Laegeforen; 1991 Sep; 111(22):2739-40. PubMed ID: 1835183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Healing by second intention in porphyria cutanea tarda.
    Frumkin A; Matlock MS
    J Dermatol Surg Oncol; 1987 Nov; 13(11):1158, 1161. PubMed ID: 3668058
    [No Abstract]   [Full Text] [Related]  

  • 5. Pseudoporphyria associated with voriconazole.
    Kwong WT; Hsu S
    J Drugs Dermatol; 2007 Oct; 6(10):1042-4. PubMed ID: 17966183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prolonged low-dose chloroquin therapy of porphyria cutanea tarda].
    Holvay E
    Orv Hetil; 1981 Jul; 122(30):1839-42. PubMed ID: 7301351
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine-induced pseudoporphyria.
    Hivnor C; Nosauri C; James W; Poh-Fitzpatrick M
    Arch Dermatol; 2003 Oct; 139(10):1373-4. PubMed ID: 14568849
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of porphyria cutanea tarda.
    Malina L
    Br J Dermatol; 1987 Jan; 116(1):139-40. PubMed ID: 3814510
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term treatment of porphyria cutanea tarda with low chloroquine doses.
    Holvay E
    Ther Hung; 1981; 29(1):42-6. PubMed ID: 7188240
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of UDPG in the treatment of porphyria cutanea tarda. Preliminary findings].
    Okolicsanyi L; Orlando R; Busnardo F; Naccarato R; Veller-Fornasa C; Polin R
    Clin Ter; 1980 Sep; 94(6):687-94. PubMed ID: 7460503
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of the therapy of porphyria cutanea tarda based on urine alkalization].
    Resl V
    Cesk Dermatol; 1971 Dec; 46(6):249-52. PubMed ID: 5135264
    [No Abstract]   [Full Text] [Related]  

  • 12. High weekly intravenous doses of desferrioxamine in porphyria cutanea tarda.
    Rocchi E; Cassanelli M; Ventura E
    Br J Dermatol; 1987 Sep; 117(3):393-6. PubMed ID: 3676087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medicine-caused itch, wounds and bullous skin in three patients with pseudoporphyria].
    Þorsteinsdóttir S; Velander MJ; Bygum A
    Ugeskr Laeger; 2015 Apr; 177(17):. PubMed ID: 25922166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of porphyria cutanea tarda.
    Finnerty EF
    Cutis; 1977 Jul; 20(1):133-5. PubMed ID: 328230
    [No Abstract]   [Full Text] [Related]  

  • 15. Low-dose oral chloroquine in the treatment of porphyria cutanea tarda.
    Ashton RE; Hawk JL; Magnus IA
    Br J Dermatol; 1984 Nov; 111(5):609-13. PubMed ID: 6498093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinico-immunological substantiation of the therapeutic effectiveness of delagil in porphyria cutanea tarda].
    Bidrat MS
    Vestn Dermatol Venerol; 1984 Oct; (10):20-3. PubMed ID: 6516569
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hemodialysis-related porphyria cutanea tarda with deferoxamine.
    Praga M; Enriquez de Salamanca R; Andres A; Nieto J; Oliet A; Perpiña J; Morales JM
    N Engl J Med; 1987 Feb; 316(9):547-8. PubMed ID: 3808000
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical studies of the treatment of porphyria cutanea tarda with antitoxic fraction of the liver and cyanocobalamin].
    Valenzano L
    Minerva Med; 1967 Oct; 58(85):3633-5. PubMed ID: 6061469
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative evaluation of the therapeutic effectiveness of small and regular doses of delagil in porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1981 Sep; (9):50-4. PubMed ID: 7029950
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis.
    Anderson KE; Goeger DE; Carson RW; Lee SM; Stead RB
    N Engl J Med; 1990 Feb; 322(5):315-7. PubMed ID: 2104958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.